Abstract

BackgroundBronchiectasis may be associated and/or co-exist with respiratory diseases as bronchial asthma and chronic obstructive pulmonary disease (COPD) or non-respiratory diseases. However, data about this association and/or co-existence is little. The objectives of the study were to determine the prevalence of bronchiectasis among admitted patients in the Chest Department in 10 years’ period (2008–2018) and to detect associated and/or co-existent respiratory diseases. In a retrospective cohort study, the diagnosis of bronchiectasis was based on chest HRCT. Data included the total number of hospitalized patients during this period, their final diagnosis, co-existing diagnosis associated with bronchiectasis, and sonographic and spirometric findings.ResultsThe total number of patients admitted in 2008–2018 was 17,531 patients. The prevalence of bronchiectasis during this period was 9.04%. COPD was the commonest suspected cause (54.1%) followed by post-tuberculosis bronchiectasis (17.1%). On admission, 63.7% had acute type 2 respiratory failure, 21.1% had decompensated cor pulmonale, 3.8% required mechanical ventilation (MV), and 1.3% required non-invasive MV. On discharge, 9.9% required long-term oxygen therapy. The presence of B lines in chest ultrasonography was recorded in 68.2% and air bronchogram in 29.1%.ConclusionsThe prevalence of bronchiectasis among admitted patients was still increasing. COPD with bronchiectasis accounted for more than half of cases. More researches are needed to identify the impact of the COPD-bronchiectasis phenotype.Trial registrationClinicalTrials.gov, NCT04101448

Highlights

  • Bronchiectasis may be associated and/or co-exist with respiratory diseases as bronchial asthma and chronic obstructive pulmonary disease (COPD) or non-respiratory diseases

  • As regards the prevalence of bronchiectasis stratified by year of diagnosis, the highest prevalence was recorded in year 2018 where the number of cases was 356 giving 22.6% prevalence rate per year followed by year 2017 in which the prevalence rate was 9.5% compared to 7% in year 2008

  • The main results showed a 9.04% prevalence of bronchiectasis among admitted patients with an increasing rate of prevalence over the years, COPD with bronchiectasis was the commonest (54.1%) diagnosis, and chronic respiratory failure indicating long-term oxygen therapy was described in 9.1% of patients

Read more

Summary

Introduction

Bronchiectasis may be associated and/or co-exist with respiratory diseases as bronchial asthma and chronic obstructive pulmonary disease (COPD) or non-respiratory diseases. Data about this association and/or co-existence is little. The objectives of the study were to determine the prevalence of bronchiectasis among admitted patients in the Chest Department in 10 years’ period (2008–2018) and to detect associated and/or coexistent respiratory diseases. Bronchiectasis may be associated and/or co-exist with respiratory diseases including bronchial asthma and chronic obstructive pulmonary disease (COPD) or non-respiratory diseases including HIV and rheumatoid arthritis. To the best of our knowledge, there is no published data about the prevalence of bronchiectasis among hospitalized patients in Egypt

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call